Author:
Ghotbi Roza,Gomez Alvin,Milani Lili,Tybring Gunnel,Syvänen Ann-Christine,Bertilsson Leif,Ingelman-Sundberg Magnus,Aklillu Eleni
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference49 articles.
1. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP . Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270: 414–423.
2. Bertilsson L, Carrillo JA, Dahl ML, Llerena A, Alm C, Bondesson U et al. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol 1994; 38: 471–473.
3. Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi LC et al. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J Pharmacol Exp Ther 1993; 265: 401–407.
4. Kroemer HK, Gautier JC, Beaune P, Henderson C, Wolf CR, Eichelbaum M . Identification of P450 enzymes involved in metabolism of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol 1993; 348: 332–337.
5. Hartter S, Ursing C, Morita S, Tybring G, von Bahr C, Christensen M et al. Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study. Clin Pharmacol Ther 2001; 70: 10–16.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献